Inc. Conjoint serves as Executive at Dogwood Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Inc. Conjoint has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 21, 2025 involved exercising options for 21,610,950 shares valued at $0.
Inc. Conjoint currently holds 21,822,333 shares of Dogwood Therapeutics, Inc. (DWTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Inc. Conjoint has been a net neutral trader of DWTX stock. They have purchased $0 and sold $0 worth of shares.
Inc. Conjoint's most recent insider trade was on Nov 21, 2025, when they sold 21,610,950 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |